Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Format: Artigo
Idioma:Inglês
Publicat: MDPI AG 2020-10-01
Col·lecció:Pharmaceuticals
Matèries:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
Accés en línia:https://www.mdpi.com/1424-8247/13/10/324
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars